Similar results were observed in this study, using the Marzese et al. cohort [11, 12] and in the WGBS data [18], which support the notion that methylation changes in TBC1D16 are a potential epigenetic driver of tumour metastasis. Here, TBC1D16 is linked to neoplasm.